Celcuity (CELC) Equity Average (2017 - 2025)
Celcuity (CELC) reported Equity Average of $108.8 million for Q4 2025, down 18.02% on a YoY basis from $132.7 million in Q4 2024, and up 34.82% quarter-over-quarter from $80.7 million in Q3 2025.
Celcuity (CELC) Equity Average (2017 - 2025) Analysis & Trends
Celcuity has reported Equity Average for 9 years, with the latest figure at $108.8 million in Q4 2025.
- For the quarter ending Q4 2025, Equity Average fell 18.02% year-over-year to $108.8 million; the trailing twelve-month figure through Dec 2025 stood at $108.8 million (down 18.02% YoY), and the FY2025 full-year result was $108.1 million, down 15.35% from the prior year.
- Equity Average for Q4 2025 stood at $108.8 million, up from $80.7 million in the prior quarter.
- The five-year high for Equity Average was $163.2 million in Q3 2024, with the low at $23.4 million in Q1 2021.
- Historically, Equity Average has averaged $92.2 million across 5 years, with a median of $94.9 million in 2022.
- Annual changes were most pronounced in 2021 — Equity Average jumped 462.3% — and 2025, when it plunged 57.79%.
- Celcuity's Equity Average stood at $71.6 million in 2021, then climbed by 23.82% to $88.6 million in 2022, then jumped by 31.23% to $116.3 million in 2023, then gained by 14.04% to $132.7 million in 2024, then declined by 18.02% to $108.8 million in 2025.
- The last three Equity Average figures came in at $108.8 million (Q4 2025), $80.7 million (Q3 2025), and $65.5 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | 3.50 Bn |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | 783.14 Mn |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | 3.76 Mn |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | 1.01 Bn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | 21.35 Mn |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 19.01 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | 516.41 Mn |
| 10 | Celcuity | 4.14 Bn | 3.42 Bn | - | 108.76 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 108.76 Mn |
| Sep 30, 2025 | 80.67 Mn |
| Jun 30, 2025 | 65.52 Mn |
| Mar 31, 2025 | 101.14 Mn |
| Dec 31, 2024 | 132.66 Mn |
| Sep 30, 2024 | 163.20 Mn |
| Jun 30, 2024 | 155.21 Mn |
| Mar 31, 2024 | 136.75 Mn |
| Dec 31, 2023 | 116.33 Mn |
| Sep 30, 2023 | 101.51 Mn |
| Jun 30, 2023 | 116.68 Mn |
| Mar 31, 2023 | 128.50 Mn |
| Dec 31, 2022 | 88.65 Mn |
| Sep 30, 2022 | 48.36 Mn |
| Jun 30, 2022 | 57.36 Mn |
| Mar 31, 2022 | 65.13 Mn |
| Dec 31, 2021 | 71.59 Mn |
| Sep 30, 2021 | 50.75 Mn |
| Jun 30, 2021 | 31.10 Mn |
| Mar 31, 2021 | 23.44 Mn |